*Storage:
*Shipping:
Bardoxolone methyl (NSC 713200; RTA 402; CDDO Methyl ester) is a synthetic triterpenoid compound known for its potential antineoplastic and anti-inflammatory properties. It functions as an activator of the Nrf2 pathway while concurrently inhibiting the NF-κB pathway.
Synonyms: RTA 402;NSC 713200;CDDO-Me
4.5
*For Research Use Only !
Change View
Size | Price | USA Stock *0-1 Day | Global Stock *5-7 Days | In Stock |
1mg | łÇ˶ÊÊ | Inquiry | Inquiry | |
10mg | łËʶÊÊ | Inquiry | Inquiry | |
100mg | łóǶÊÊ | Inquiry | Inquiry | |
250mg | łÇ§ď¶ÊÊ | Inquiry | Inquiry | |
1g | ł§ď˶ÊÊ | Inquiry | Inquiry |
łÇ˶ÊÊ
łËʶÊÊ
łóǶÊÊ
łÇ§ď¶ÊÊ
ł§ď˶ÊÊ
In Stock
- +
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 218600-53-4 |
Formula : | C32H43NO4 |
M.W : | 505.69 |
SMILES Code : | COC([C@]12[C@](CC(C)(CC2)C)([H])[C@]3([H])[C@@](CC1)([C@]4(C([C@@]5([C@@](C(C)(C(C(C#N)=C5)=O)C)([H])CC4)C)=CC3=O)C)C)=O |
Synonyms : |
RTA 402;NSC 713200;CDDO-Me
|
MDL No. : | MFCD11983137 |
InChI Key : | WPTTVJLTNAWYAO-KPOXMGGZSA-N |
Pubchem ID : | 400769 |
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H332-H335 |
Precautionary Statements: | P261-P280-P305+P351+P338 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01500798 | Chronic Kidney Disease ... More >> Type 2 Diabetes Less << | Phase 1 | Terminated(IDMC recommendation... More >> for safety concerns) Less << | - | - |
NCT01576887 | End-Stage Renal Disease ... More >> Type 2 Diabetes Mellitus Less << | Phase 2 | Withdrawn(IDMC recommendation ... More >>for safety concerns) Less << | October 2013 | - |
NCT00529113 | Pancreatic Neoplasms ... More >> Pancreatic Cancer Less << | Phase 1 Phase 2 | Terminated(To pursue other ind... More >>ications) Less << | - | United States, Colorado ... More >> Rocky Mountain Cancer Center (US Oncology) Denver, Colorado, United States United States, Florida Cancer Centers of Florida (US Oncology) Ocoee, Florida, United States United States, Indiana Central Indiana Cancer Centers (US Oncology) Indianapolis, Indiana, United States United States, Texas Sammons Cancer Center (US Oncology) Dallas, Texas, United States, 75246 United States, Washington Northwest Cancer Specialist- Vancouver Cancer Specialist (US Oncology) Vancouver, Washington, United States Less << |
NCT01689116 | Healthy Volunteers | Phase 1 | Completed | - | United States, Wisconsin ... More >> Spaulding Clinical Research, LLC West Bend, Wisconsin, United States, 53012 Less << |
NCT01574365 | Chronic Kidney Disease|Type 2 ... More >>Diabetes Less << | PHASE2 | TERMINATED | 2025-11-13 | Toride City, Ibaraki, Japan |
NCT01572610 | Chronic Kidney Disease|Type 2 ... More >>Diabetes Less << | PHASE2 | TERMINATED | 2025-11-13 | Koga city, Ibaraki, Japan |
NCT01655186 | Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << | Phase 2 | Withdrawn(IDMC recommendation ... More >>for safety concerns) Less << | October 2013 | - |
NCT00508807 | Lymphoid Malignancies|Solid Tu... More >>mors Less << | PHASE1 | COMPLETED | 2025-12-09 | UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less << |
NCT00550849 | Liver Disease | Phase 1 Phase 2 | Terminated(Enrollment disconti... More >>nued after second cohort completed.) Less << | - | United States, Florida ... More >> Orlando Clinical Research Center Orlando, Florida, United States, 32809 Less << |
NCT01598363 | Healthy Volunteers | Phase 1 | Completed | - | United States, Wisconsin ... More >> Spaulding Clinical Research, LLC West Bend, Wisconsin, United States, 53095 Less << |
NCT01563562 | Hepatic Impairment ... More >> Healthy Less << | Phase 1 | Completed | - | United States, Florida ... More >> University of Miami School of Medicine Miami, Florida, United States, 33136 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Less << |
NCT01551446 | Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << | Phase 1 | Withdrawn(IDMC recommendation ... More >>for safety concerns) Less << | October 2013 | - |
NCT01503866 | Healthy | Phase 1 | Completed | - | United States, Wisconsin ... More >> Covance Clinical Research Unit Madison, Wisconsin, United States, 53704 Less << |
NCT00664027 | Diabetic Nephropathy | Phase 2 | Completed | - | United States, Texas ... More >> West Houston Clinical Research Services Houston, Texas, United States, 77055 Renal Associates, PA San Antonio, Texas, United States, 78215 DGD Research San Antonio, Texas, United States, 78229 Less << |
NCT01549769 | Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << | Phase 1 | Terminated(IDMC recommendation... More >> for safety concerns) Less << | - | - |
NCT00535314 | Malignant Melanoma | Phase 2 | Withdrawn | - | - |
NCT02316821 | Chronic Kidney Disease ... More >> Type 2 Diabetes Less << | Phase 2 | Completed | - | Japan ... More >> Tokyo, Japan Less << |
NCT01351675 | Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << | Phase 3 | Terminated(IDMC recommendation... More >> for safety concerns) Less << | - | - |
NCT01053936 | Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << | Phase 2 | Completed | - | - |
NCT01461161 | Healthy Volunteers | Phase 1 | Completed | - | United States, Wisconsin ... More >> Spaulding Clinical Research West Bend, Wisconsin, United States, 53095 Less << |
NCT03366337 | IgA Nephropathy ... More >> CKD Associated With Type 1 Diabetes Focal Segmental Glomerulosclerosis Autosomal Dominant Polycystic Kidney Less << | Phase 2 | Recruiting | August 2019 | - |
NCT00811889 | Chronic Kidney Disease ... More >> Type 2 Diabetes Diabetic Nephropathy Less << | Phase 2 | Completed | - | - |
NCT03550443 | Diabetic Kidney Disease | Phase 3 | Recruiting | March 2022 | Japan ... More >> Japan Community Health care Organization Sendai Hospital Recruiting Sendai, Miyagi, Japan, 981-0912 Less << |
NCT02657356 | Connective Tissue Disease-Asso... More >>ciated Pulmonary Arterial Hypertension Less << | Phase 3 | Recruiting | June 2020 | - |
NCT00529438 | Advanced Solid Tumors|Lymphoid... More >> Malignancies Less << | PHASE1 | COMPLETED | 2008-12-01 | Beth Israel Deaconess Medical ... More >>Center, Boston, Massachusetts, 02215, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States Less << |
NCT03264079 | Healthy Volunteers | Phase 1 | Completed | - | United States, Ohio ... More >> Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Less << |
NCT02036970 | Pulmonary Arterial Hypertensio... More >>n Pulmonary Hypertension Interstitial Lung Disease Idiopathic Interstitial Pneumonia Idiopathic Pulmonary Fibrosis Sarcoidosis Respiratory Bronchiolitis Associated Interstitial Lung Disease Desquamative Interstitial Pneumonia Cryptogenic Organizing Pneumonia Acute Interstitial Pneumonitis Idiopathic Lymphoid Interstitial Pneumonia Idiopathic Pleuroparenchymal Fibroelastosis Less << | Phase 2 | Completed | - | - |
NCT03019185 | Alport Syndrome | Phase 2 Phase 3 | Active, not recruiting | December 2020 | - |
NCT03749447 | Chronic Kidney Diseases|Alport... More >> Syndrome|Autosomal Dominant Polycystic Kidney Less << | PHASE3 | TERMINATED | 2023-08-23 | University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Apogee Clinical Research, Huntsville, Alabama, 35805, United States|Arizona Kidney Disease and Hypertension Research Services, PLLC, Glendale, Arizona, 85306, United States|Centricity Research Phoenix Multispecialty, Mesa, Arizona, 85206, United States|California Institute Renal Research, La Mesa, California, 91942, United States|Academic Medical Research Institute, Los Angeles, California, 90022, United States|David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, United States|Apex Research of Riverside, Riverside, California, 92505, United States|Rady Children's Hospital - San Diego, San Diego, California, 92123, United States|University of California San Francisco - Children's Renal Center, San Francisco, California, 94143, United States|University of California, San Francisco, San Francisco, California, 94143, United States|Western Nephrology, Arvada, Colorado, 80002, United States|University of Colorado Anschutz Medical Center, Aurora, Colorado, 80045, United States|Colorado Kidney Care, PC, Denver, Colorado, 80230, United States|South Florida Research Institute, Lauderdale Lakes, Florida, 33313, United States|Innovation Medical Research, Inc., Palmetto Bay, Florida, 33157, United States|USF Health South Tampa Center, Tampa, Florida, 33606, United States|Florida Premier Research Institute, LLC, Winter Park, Florida, 32789, United States|Emory University School of Medicine, Atlanta, Georgia, 30322, United States|Boise Kidney & Hypertension, PLLC, Caldwell, Idaho, 83605, United States|Boise Kidney & Hypertension, PLLC, Meridian, Idaho, 83642, United States|Northwestern University, Chicago, Illinois, 60611, United States|Nephrology Research NorthShore University Health System, Evanston, Illinois, 60201, United States|University of Kansas Medical Center, Kansas City, Kansas, 66224, United States|Renal Associates of Baton Rouge, Baton Rouge, Louisiana, 70808, United States|Northwest Louisiana Nephrology, Shreveport, Louisiana, 71101, United States|The Johns Hopkins University, Baltimore, Maryland, 21287, United States|Tufts Medical Center - Division of Nephrology, Boston, Massachusetts, 02110, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Nephrology Center, PC, Kalamazoo, Michigan, 49007, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Children's Mercy Hospital and Clinics, Kansas City, Missouri, 64108, United States|Clinical Research Consultants, LLC, Kansas City, Missouri, 64111, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|KSOSN, Las Vegas, Nevada, 89128, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Columbia University Medical Center, New York, New York, 10032, United States|Mountain Kidney & Hypertension Associates, Asheville, North Carolina, 28801, United States|North Carolina Nephrology, Cary, North Carolina, 27511, United States|Metrolina Nephrology Associates, Charlotte, North Carolina, 28208, United States|Duke University Medical Center, Durham, North Carolina, 27701, United States|Metrolina Nephrology Associates, Gastonia, North Carolina, 28054, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Remington-Davis Clinical Research, Columbus, Ohio, 43215, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Northeast Clinical Research Center, Bethlehem, Pennsylvania, 18017, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15224, United States|Columbia Nephrology Associates, PA, Columbia, South Carolina, 29203, United States|South Carolina Nephrology & Hypertension Center, Inc, Orangeburg, South Carolina, 29118, United States|Arlington Nephrology, Arlington, Texas, 76015, United States|Research Management, Inc., Austin, Texas, 78751, United States|Renal Disease Research Institute, Dallas, Texas, 75204, United States|DaVita Med Center, Houston, Texas, 77004, United States|Southwest Houston Research, Houston, Texas, 77099, United States|Clinical Advancement Center, San Antonio, Texas, 78215, United States|University of Vermont Medical Center, Burlington, Vermont, 05401, United States|Nephrology Associates of Northern Virginia, Inc., Fairfax, Virginia, 22033, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Milwaukee Nephrologists, SC, Wauwatosa, Wisconsin, 53226, United States|John Hunter Hospital, New Lambton, New South Wales, 2305, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, 4029, Australia|Melbourne Renal Research Group, Reservoir, Victoria, 3073, Australia|The Royal Melbourne Hospital, Parkville, 3050, Australia|Chu Grenoble Alpes, Grenoble, 38043, France|Hopital Necker, Universite Paris Descartes, Paris, 75015, France|Japanese Red Cross Nagoya Daini Hospital, Nagoya-shi, Aichi, 466-8650, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan|Kobe University Hospital, Kobe City, Hyogo, 650-0017, Japan|Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, 213-8587, Japan|St Marianna University Hospital, Kawasaki, Kanagawa, 216-8511, Japan|JCHO Sendai Hospital, Sendai-shi, Miyagi, 981-3281, Japan|Kitano Hospital, Osaka-shi, Osaka, 530-8480, Japan|Osaka University Hospital, Suita, Osaka, 565-8971, Japan|Saga University Hospital, Saga-shi, Saga, 849-8501, Japan|Saitama Children's Medical Center, Saitama-shi, Saitama, 330-8777, Japan|Juntendo University Hospital, Bunkyō-Ku, Tokyo, 113-8431, Japan|Jutendo University Hospital, Bunkyō-Ku, Tokyo, 113-8431, Japan|Tokyo Metropolitan Children's Medical Center, Fuchū, Tokyo, 183-8561, Japan|Toranomon Hospital, Minato-Ku, Tokyo, 105-8470, Japan|Tokyo Women's Medical University Hospital, Shinjuku-Ku, Tokyo, 162-8666, Japan|Niigata University Medical and Dental Hospital, Niigata, 951-8520, Japan|Local Incorporated Administrative Agency Osaka City Hospital Organization Osaka City General Hospital, Osaka, 834-0021, Japan|Puerto Rico Clinical and Translational Research Consortium (PRCTRC), Rio Piedras, 00935, Puerto Rico|Fundacio Puigvert, Barcelona, Cataluna, 08025, Spain|Hospital Virgen de la Arrixaca, El Palmar, Murcia, 30120, Spain Less << |
NCT03068130 | Pulmonary Hypertension | PHASE3 | TERMINATED | 2020-09-30 | Banner University Medical Cent... More >>er, Phoenix Advanced Lung Disease Institute, Phoenix, Arizona, 85004, United States|Arizona Pulmonary Specialists, Phoenix, Arizona, 85012, United States|Cedars Sinai Medical Center, Beverly Hills, California, 90211, United States|University of California San Diego, La Jolla, California, 92093, United States|VA Healthcare System of Greater Los Angeles, Los Angeles, California, 90073, United States|David Geffen School of Medicine UCLA, Los Angeles, California, 90095, United States|University of California Davis Medical Center - Division of Pulmonary and Critical Care, Sacramento, California, 95817, United States|Harbor - UCLA Medical Center, Torrance, California, 90502, United States|University of Colorado Denver - Division of Pulmonary Sciences, Aurora, Colorado, 80045, United States|Georgetown University Medical Center - Department of Rheumatology, Washington, District of Columbia, 20007, United States|University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|Cleveland Clinic of Florida, Weston, Florida, 33331, United States|Augusta University, Augusta, Georgia, 30912, United States|Piedmont-Georgia Lung, Austell, Georgia, 30106, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|University of Illinois at Chicago, Chicago, Illinois, 60612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Kentuckiana Pulmonary Associates, Louisville, Kentucky, 40202, United States|Maine Medical Center - Division of Pulmonary and Critical Care Medicine, Portland, Maine, 04102, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Boston University School of Medicine, Boston, Massachusetts, 02118, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, 87131, United States|Winthrop University Hospital, Mineola, New York, 11501, United States|NYU Langone Medical Center, New York, New York, 10016, United States|University of Rochester - University of Rochester Medical Center, Rochester, New York, 14642, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|The Lindner Clinical Trial Center, Cincinnati, Ohio, 45219, United States|University of Cincinnati - Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine, Cincinnati, Ohio, 45267, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, 43210, United States|Oklahoma Heart Hospital, Oklahoma City, Oklahoma, 73120, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|The Methodist Hospital Research Institute, Houston, Texas, 77030, United States|The University of Texas - Health Science Center & Medical School at Houston, Houston, Texas, 77030, United States|University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston, Texas, 77030, United States|University of Utah, Salt Lake City, Utah, 84132, United States|Aurora Health Care, Milwaukee, Wisconsin, 53215, United States|Centro Médico Dra de Salvo, Buenos Aires, Ciudad Autónoma De BuenosAires, C1426ABP, Argentina|Instituto de Investigaciones Clínicas Mar Del Plata, Buenos Aires, Mar Del Plata, B7600FZN, Argentina|Hospital Privado Centro Médico de Córdoba, Cordoba, X5016KEH, Argentina|Instituto de Cardiologia de Corrientes Juana Francisca Cabral, Corrientes, W3400AMZ, Argentina|Instituto Cardiovascular de Rosario, Rosario, S2000DSR, Argentina|Hospital Provincial Dr Jose Maria Cullen, Santa Fe, S3000EPV, Argentina|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, 2010, Australia|John Hunter Hospital, New Lambton, New South Wales, 2305, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Royal Hobart Hospital, Hobart, Tasmania, 7000, Australia|UZ Leuven, Leuven, Vlaams Brabant, 3000, Belgium|Hospital Erasme, Brussels, 1070, Belgium|Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-074, Brazil|Hospital Dia do Pulm?o, Blumenau, Santa Catarina, 89010-000, Brazil|Instituto do Cora??o - HCFMUSP, S?o Paulo, 05403-900, Brazil|Peter Lougheed Centre, Calgary, Alberta, T1Y 6J4, Canada|Vancouver General Hospital, Vancouver, British Columbia, V5Z 1M9, Canada|London Health Sciences Centre, London, Ontario, N6A 5W9, Canada|Centre Hospitalier de l'Université Laval, Sainte Foy, Quebec, G1V 4G5, Canada|Vseobecna fakultni nemocnice v Praze, Prague, 128 00, Czechia|Institut klinicke a experimentalni mediciny, Prague, 140 00, Czechia|Universitatsklinkum Carl Gustav Carus an der Tu, Dresden, 01307, Germany|Universitatsklinikum Hamburg Eppendorf, Hamburg, 20246, Germany|Thorax Klinik, Heidelberg, 69126, Germany|Hadassah University Hospital Ein Kerem, Jerusalem, 91120, Israel|Rabin Medical Center, Petah Tikva, 49100, Israel|Nippon Medical School Hospital, Tokyo, Bunkyo-ku, 113-8603, Japan|Kobe University Hospital, Kobe, Hyogo, 6500017, Japan|Kitasato University Hospital, Sagamihara, Kanagawa, 252-0375, Japan|Kyorin University Hospital, Tokyo, Mitaka-shi, 181-8611, Japan|National Hospital Organization Okayama Medical Center, Okayama-shi, Okayama, 701-1192, Japan|Chiba University Hospital, Chiba, 260-8677, Japan|Hokkaido University Hospital, Sapporo, 0608648, Japan|Kurume University Medical Center, Sendai-shi, 980-8574, Japan|National Cerebral and Cardiovascular Center, Suita, 5658565, Japan|Instituto Nacional de Cardiologia Dr. Ignacio Chavez, Ciudad de Mexico, Distrito Federal, 14080, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Distrito Federal, 14000, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Nuevo León, Monterrey, 64460, Mexico|Unidad de Investigación Clínica En Medicina SC, Monterrey, Nuevo Leon, 64718, Mexico|Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, 1007 MB, Netherlands|Philippine Heart Center, Quezon City, Metro Manila, 1100, Philippines|Makati Medical Center, Makati, 1229, Philippines|Philippine General Hospital (PGH), Manila, Philippines|Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario Puerta de Hierro, Majadahonda, Spain|Hospital Virgen de La Salud, Toledo, 45004, Spain|Golden Jubilee National Hospital, Glasgow, G81 4HX, United Kingdom|Royal Free Hospital, London, NW3 2QG, United Kingdom Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 1.98mL 0.40mL 0.20mL | 9.89mL 1.98mL 0.99mL | 19.77mL 3.96mL 1.98mL |
Tags: 218600-53-4 synthesis path| 218600-53-4 SDS| 218600-53-4 COA| 218600-53-4 purity| 218600-53-4 application| 218600-53-4 NMR| 218600-53-4 COA| 218600-53-4 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL